相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disulfiram reactivates latent HIV-1 expression through depletion of the phosphatase and tensin homolog
Genevieve Doyon et al.
AIDS (2013)
BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
Daniela Boehm et al.
CELL CYCLE (2013)
Histone Deacetylase Inhibitors (HDACis) That Release the Positive Transcription Elongation Factor b (P-TEFb) from Its Inhibitory Complex Also Activate HIV Transcription
Koen Bartholomeeusen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A Novel PCR Assay for Quantification of HIV-1 RNA
Liang Shan et al.
JOURNAL OF VIROLOGY (2013)
The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
Zichong Li et al.
NUCLEIC ACIDS RESEARCH (2013)
Reactivation of latent HIV by histone deacetylase inhibitors
Kotaro Shirakawa et al.
TRENDS IN MICROBIOLOGY (2013)
Eliminating the latent HIV reservoir by reactivation strategies Advancing to clinical trials
Thomas A. Rasmussen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay
Gregory M. Laird et al.
PLOS PATHOGENS (2013)
Effect of Histone Deacetylase Inhibitors on HIV Production in Latently Infected, Resting CD4+ T Cells From Infected Individuals Receiving Effective Antiretroviral Therapy
Jana Blazkova et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
Camellia Banerjee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro
Brian A. DeChristopher et al.
NATURE CHEMISTRY (2012)
Reactivation of Latent HIV-1 by Inhibition of BRD4
Jian Zhu et al.
CELL REPORTS (2012)
Towards an HIV cure: a global scientific strategy
Steven G. Deeks
NATURE REVIEWS IMMUNOLOGY (2012)
HIV latency: experimental systems and molecular models
Shweta Hakre et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Curing HIV: Pharmacologic Approaches to Target HIV-1 Latency
Shailesh K. Choudhary et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation
Sifei Xing et al.
JOURNAL OF VIROLOGY (2011)
The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit
Jonathan Karn
CURRENT OPINION IN HIV AND AIDS (2011)
Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
Rajeev Mehla et al.
PLOS ONE (2010)
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Nancie M. Archin et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Xavier Contreras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Challenge of Finding a Cure for HIV Infection
Douglas D. Richman et al.
SCIENCE (2009)
Resting CD4+ T cells from human immunodeficiency virus type I (HIV-1)-infected individuals carry integrated HIV-1 Genomes within actively transcribed host genes
YF Han et al.
JOURNAL OF VIROLOGY (2004)
Prostratin antagonizes HIV latency by activating NF-κB
SA Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV:: Intrinsic stability predicts lifelong persistence
MC Strain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
HIV-1 integration in the human genome favors active genes and local hotspots
ARW Schröder et al.
CELL (2002)
Effects of prostratin on T-cell activation and human immunodeficiency virus latency
YD Korin et al.
JOURNAL OF VIROLOGY (2002)
Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART
J Kulkosky et al.
BLOOD (2001)
Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1
M Baba et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2000)
分享论文
